The note is significant as it signals a rift between the company’s founders and some of its investors. It is reminiscent of the recent boar...

From Swiggy's mega funding round to Pegasus spyware explainer and Bezos's blastoff to space, here's a quick look at the top tech news today.

Under the COVID Protection Policy, the company will contribute an amount equivalent to five years of the last drawn gross annual salary to ...

The funds would be utilised for procuring ventilators, personal protective equipment (PPE) and medicines for the states reporting maximum n...

With the launch, the company has become the first Indian and second global firm to develop the drug, Mankind Pharma said in a statement. Th...

The company is also looking at increasing its exports substantially to USD 100-150 USD million in the next three years from the present USD...

Terming the decision to ban 344 fixed dose combination medicines as "arbitrary and unfair", pharma industry has said it feels let down by t...

Mankind Pharma has launched an anti-diabetic product 'Dynaglipt' targeting the middle class and rural diabetic patients.

Having established itself in Sri Lanka, Cambodia and East Africa, the company now plans to offer its products in South, West and North Afri...

ChrysCapital, which purchased the stake in 2007 for $24 mn will earn a 9-fold return, striking one of the largest exits in pharma sector by...

For the 12 months period ended April 2011, India's rural drug market grew 18.8% compared with 10.9% in the previous year.

It could be curtains down for advertisements of controversial emergency contraceptive pills (ECPs) such as Cipla’s i-pill and Mankind Pharm...

Escalating cost of raw materials has pushed Indian drugmakers to a corner. While the prices of bulk drugs imported from China have increase...

Mankind Pharma, which registered the highest growth in the industry over the last one year, is venturing into the Rs 1,000-crore anti-psych...

Pharmaceutical company, Mankind Pharma has said it will set up manufacturing and research facilities in Himachal Pradesh and National Capit...

Unlisted drug maker Mankind Pharma Ltd hopes this year to sell upto 10 per cent of its equity to domestic investors in a bid to raise funds...